Federated Hermes
BCAB icon

Federated Hermes’s BioAtla BCAB Stock Holding History

Federated Hermes’s Portfolio BCAB Stock Details BCAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-41
Closed -$703 – 2070
2025
Q1 		$703 Buy
41
+6
+17% +$128 ﹤0.01% 2012
2024
Q4 		$1.05K Hold
35
– – ﹤0.01% 2020
2024
Q3 		$3.11K Sell
35
-40
-53% -$3.35K ﹤0.01% 1906
2024
Q2 		$5.11K Buy
+75
New +$8.92K ﹤0.01% 1836
2024
Q1 		– Sell
-57
Closed -$6.96K – 2038
2023
Q4 		$6.96K Buy
57
+16
+39% +$1.39K ﹤0.01% 1822
2023
Q3 		$3.49K Buy
+41
New +$5.23K ﹤0.01% 1921

Other funds holding BCAB

ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.66B AUM 340.85% 1-Year Est. Return